Copanlisib domestic price

Copanlisib is an oral anticancer drug that belongs to a class of drugs called phosphatidylinositol 3-kinase (PI3K) inhibitors. Its main function is to prevent the growth and spread of cancer cells by inhibiting the PI3K signaling pathway. This signaling pathway plays an important role in a variety of malignancies, so copanliside is used to treat certain types of cancer.

Copanliside has just been launched in China and has not yet been included in medical insurance. The specific price may not be determined yet. Please consult your local pharmacy for details. There is only the American version of the original drug available abroad, and the price is as high as more than 70,000 yuan.

Copanliside is commonly used to treat relapsed or refractory synovial sarcoma (follicular lymphoma) and diffuse large B-cell lymphoma (diffuse large B-cell lymphoma). These types of lymphoma are hematological malignancies that may be insensitive to traditional treatments or may have relapsed, thus requiring new treatment options.

Copanliside acts on the PI3K signaling pathway of cancer cells, preventing the growth of cancer cells and inducing apoptosis (programmed cell death). This makes it a promising treatment option, especially when other treatments fail to effectively control the cancer.

However, copanlixet may also cause some side effects, including nausea, vomiting, diarrhea, fatigue, and high blood sugar. Therefore, patients receiving this medication need to be closely monitored and work closely with their medical professional to ensure optimal treatment and minimize adverse effects.

In summary, copanliside is a new drug used to treat certain types of malignant lymphoma. It inhibits thePI3Ksignaling pathway to prevent the growth and spread of cancer cells. However, patients need to follow their doctor's advice when using this drug and be aware of possible side effects.